OTC Rock (An OTC Investor)

The time has come to take back what is rightfully ours. It's time to galvanize and take action. Together, we can make a difference and achieve our goals. Let's seize this opportunity and make it happen!

Our collaboration is dedicated to finding practical solutions for the long-standing problem of how to live longer and better. By 2030, the number of people aged 65 and over will exceed one billion, so we need to shift our traditional approaches to medicine towards a more proactive strategy focusing on prevention and patient participation while firmly rooted in the science of aging. To achieve this, we are incorporating a Software as a Service (SaaS) solution that uses multi-omic testing and AI algorithms to identify early signs of organ distress, allowing for timely interventions and improving therapeutic outcomes. Our precision medicine suite incorporates patient profiling, proteomics, genomics, and AI to enhance lifespan and, more importantly, healthspan. The new Enzolytics AI platform offers real-world data analytics capabilities to discover novel biomarkers and targets and to stratify patient cohorts for research purposes. We are excited to be taking bold new steps in exciting directions, expanding our horizons as we work towards achieving our goal. @ZainKhalpey #ENZC #LONGEVITY #AI finance.yahoo.com/news/enzol…